Condition: Type B Aortic Dissection · Sponsor: Intressa Vascular SA
This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.
This description comes directly from the study's public registry record.
Virginie Martin · +3281 71 99 41 · virginie.martin@intressavascular.com
Always discuss trial participation with your own doctor first.
| Ziekenhuis Oost-Limburg | Genk, Belgium | Not Yet Recruiting |
| UZ Leuven | Leuven, Belgium | Not Yet Recruiting |
| CHU Liège | Liège, Belgium | Recruiting |
| Acibadem City Clinic University Hospital and Cardiovascular Center | Sofia, Bulgaria | Not Yet Recruiting |
| Hopital Européen Georges Pompidou AP-HP | Paris, France | Not Yet Recruiting |
| Universitätsklinikum Schleswig-Holstein | Kiel, Germany | Recruiting |
| Universitätsklinikum Leipzig AöR | Leipzig, Germany | Recruiting |
| University Hospital of Münster | Münster, Germany | Not Yet Recruiting |
| University Clinical Centre of Serbia | Belgrade, Serbia | Not Yet Recruiting |
| Republican Research Centre of Emergency Medicine | Tashkent, Uzbekistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06675617